Key Metrics of Capstone Holding Corp.
Revenue$48.4MFY 2023
Operating income−$1.3M
Net profit−$3.8M
Shareholders' equity$2.4M
Market cap$2.4MCAPS · $2.58
Competitors10identified
About Capstone Holding Corp.
Sectors
Company details
- Listed
- Nasdaq: CAPS
Operational Areas of Capstone Holding Corp.
Pharmaceuticals & Healthcare›Biotechnology & Vaccines
Company summary
Legal nameCapstone Holding Corp.
TickerCAPS
ExchangeNasdaq
CountryUnited States
SEC CIK0000887151
Listed since—
IndustryRETAIL: Building Materials
SectorPharmaceuticals & Healthcare · Biotechnology & Vaccines
Website—
US market & SEC filings
CAPS · Nasdaq · SEC CIK 0000887151
Last price · 23 Oct 2026
$2.58
−6.18%
Market cap$2.4M
P/E—On FY 2023 diluted EPS
Volume27,458
SectorConsumer DiscretionaryRETAIL: Building Materials
Country · IPOUnited States
CAPS share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered office—
GSTIN—
Email—
Website—
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of Capstone Holding Corp.
Competitors10identified
Countries1most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Part of Vertex Pharmaceuticals. | vrtx.com | 1991 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | modernatx.com | 2018 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | bd.com | — | United States | |
| Part of Illumina. | illumina.com | 2000 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | guardanthealth.com | 2018 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | revvity.com | — | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | exelixis.com | 2000 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | neurocrine.com | 1996 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | biomarin.com | 1999 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | bio-rad.com | 1980 | United States |
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Business activities and related parties
Principal business activities and related-party transactions are read from MGT-7 and AOC-4 filings.
Filings
No filings on record yet.